Grand Pharmaceutical Group Limited (HK:0512) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Grand Pharmaceutical Group Limited has announced the resignation of Dr. Shi Lin as an executive director effective from 24 June 2024, as she wishes to focus on personal endeavors. Concurrently, Dr. Xing Li Na has been appointed as a non-executive director beginning the same date, bringing in a wealth of experience from the pharmaceutical industry and regulatory review work. The company has expressed appreciation for Dr. Shi’s contributions and welcomed Dr. Xing to her new role.
For further insights into HK:0512 stock, check out TipRanks’ Stock Analysis page.